Journal article
The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: Results of an aborted randomised placebo-controlled trial
SJ Zhou, SA Skeaff, P Ryan, LW Doyle, PJ Anderson, L Kornman, AJ Mcphee, LN Yelland, M Makrides
Trials | BMC | Published : 2015
Abstract
Background: Concern that mild iodine deficiency in pregnancy may adversely affect neurodevelopment of offspring has led to recommendations for iodine supplementation in the absence of evidence from randomised controlled trials. The primary objective of the study was to investigate the effect of iodine supplementation during pregnancy on childhood neurodevelopment. Secondary outcomes included pregnancy outcomes, maternal thyroid function and general health. Methods: Women with a singleton pregnancy of fewer than 20weeks were randomly assigned to iodine (150μg/d) or placebo from trial entry to birth. Childhood neurodevelopment was assessed at 18months by using Bayley Scales of Infant and Toddl..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This study was funded by the NHMRC of Australia (grant #626800). Data collection, analysis and interpretation were conducted independently of the funding body. The Women's & Children's Health Research Institute provided infrastructure support. We thank Jennie Louise for her assistance with statistical analysis. MM is supported by an NHMRC Principal Research Fellowship (#1061704). PJA is supported by an NHMRC Senior Research Fellowship (#628371). LNY is supported by an NHMRC Early Career Research Fellowship (#1052388).